---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-133133"
form_type: "8-K"
ticker: "BTMD"
cik: "0001819253"
company_name: "biote Corp."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T19:41:47.370173+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Biote reports Q1 revenue $46.8M (+4.4%), net loss narrows to $5.8M; reaffirms 2024 guidance

## Summary
- Revenue $46.8M (+4.4% YoY); procedure revenue $37.4M (+6.6%).
- Net loss $(5.8)M vs $(21.4)M prior year; EPS $(0.06) vs $(0.39).
- Adjusted EBITDA $14.2M (+8.0%); margin 30.2% (+100bps).
- Gross margin 71.4% (+240bps) on improved mix.
- BioteRx launch progressing; reaffirms FY2024 guidance with H2 acceleration.

## SEC filing metadata
- accession: 0001193125-24-133133
- form_type: 8-K
- ticker: BTMD
- cik: 0001819253
- company_name: biote Corp.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819253/000119312524133133/0001193125-24-133133-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819253/000119312524133133/d802970d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-133133
- JSON: https://secwatch.observer/filing/0001193125-24-133133.json
- Plain text: https://secwatch.observer/filing/0001193125-24-133133.txt

## Key facts
- Earnings Releases
  biote Corp. reported first quarter ended March 31, 2024 results: revenue Revenue of $46.8 million, net income Net loss of $(5.8) million, EPS basic and diluted loss per share attributable to biote Corp. stockholders of $(0.06). Guidance reaffirmed.
  - Period: first quarter ended March 31, 2024
  - Revenue: Revenue of $46.8 million
  - Net income: Net loss of $(5.8) million
  - EPS: basic and diluted loss per share attributable to biote Corp. stockholders of $(0.06)
  - Guidance: reaffirmed
  - Result: reported results
  source text: for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights (All financial result comparisons made are against the prior-year period) • Revenue of $46.8 million, up 4.4% • Procedure revenue of $37.4 million, up 6.6% • Gross profit margin of 71.4%, an approximately 240-basis point increase • Net loss of $(5.8) million, representing net
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819253/000119312524133133/0001193125-24-133133-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.